Angiotensin Receptor Antagonists < Angiotensin-Converting Enzyme 2 < Angiotensin-Converting Enzyme Inhibitors

Facettes : Author.f

List of bibliographic references

Number of relevant bibliographic references: 49.
[0-20] [0 - 20][0 - 49][20-40]

Ident.	Authors (with country if any)	Title
000280 (2021)	Hardeep Kaur ; Phulen Sarma ; Anusuya Bhattacharyya ; Manisha Prajapat ; Subodh Kumar ; Ajay Prakash ; Bikash Medhi	Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
000407 (2021)	Riadh Badraoui ; Mohd Adnan ; Fevzi Bardakci ; Mousa M. Alreshidi	Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism.
000422 (2021)	Eric Duverger ; Guillaume Herlem ; Fabien Picaud	A potential solution to avoid overdose of mixed drugs in the event of Covid-19: Nanomedicine at the heart of the Covid-19 pandemic.
000469 (2020)	Zeinab Imani-Saber ; Hajar Vaseghi ; Mojdeh Mahdian ; Fatemeh Safari ; Mohsen Ghadami	Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk.
000602 (2020)	Caio P. Gomes ; Danilo E. Fernandes ; Fernanda Casimiro ; Gustavo F. Da Mata ; Michelle T. Passos ; Patricia Varela ; Gianna Mastroianni-Kirsztajn ; João Bosco Pesquero	Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics.
000603 (2020)	Gisela Canedo-Marroquín ; Farides Saavedra ; Catalina A. Andrade ; Roslye V. Berrios ; Linmar Rodríguez-Guilarte ; María C. Opazo ; Claudia A. Riedel ; Alexis M. Kalergis	SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments.
000610 (2020)	Mogahed Ismail Hassan Hussein ; Ahmed Abdalazim Dafallah Albashir ; Omer Ali Mohamed Ahmed Elawad ; Anmar Homeida	Malaria and COVID-19: unmasking their ties.
000678 (2021)	Jia Fu ; Qianqian Jia ; Huaxin Zhou ; Liyang Zhang ; Saisai Wang ; Peida Liang ; Yanni Lv ; Shengli Han	Cell membrane chromatography for the analysis of the interaction between chloroquine and hydroxychloroquine with ACE2 receptors.
000852 (2020)	Meshari Alazmi ; Olaa Motwalli	Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates.
000956 (2021)	Jacques Fantini ; Henri Chahinian ; Nouara Yahi	Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19.
000981 (2020)	Gerardo Casucci ; Domenico Acanfora ; Raffaele Antonelli Incalzi	The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets.
000A75 (2020)	Yan Wang ; Lei Chen	Tissue distributions of antiviral drugs affect their capabilities of reducing viral loads in COVID-19 treatment.
000A80 (2021)	Pravindra Kumar ; Ashok Kumar Sah ; Greesham Tripathi ; Anjali Kashyap ; Avantika Tripathi ; Rashmi Rao ; Prabhu C. Mishra ; Koustav Mallick ; Amjad Husain ; Manoj Kumar Kashyap	Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
000B63 (2020)	Y-X Bai ; Y-H Xu ; X. Wang ; C. Sun ; Y. Guo ; S. Qiu ; K-W Ma	Advances in SARS-CoV-2: a systematic review.
000B71 (2020)	Satya P. Gupta	Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
000B91 (2020)	Philippe Caron	Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient management.
000C07 (2020)	Pablo Zubiaur ; Dora Koller ; Miriam Saiz-Rodríguez ; Marcos Navares-G Mez ; Francisco Abad-Santos	Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19).
000C37 (2020)	Nan Wang ; Shengli Han ; Rui Liu ; Liesu Meng ; Huaizhen He ; Yongjing Zhang ; Cheng Wang ; Yanni Lv ; Jue Wang ; Xiaowei Li ; Yuanyuan Ding ; Jia Fu ; Yajing Hou ; Wen Lu ; Weina Ma ; Yingzhuan Zhan ; Bingling Dai ; Jie Zhang ; Xiaoyan Pan ; Shiling Hu ; Jiapan Gao ; Qianqian Jia ; Liyang Zhang ; Shuai Ge ; Saisai Wang ; Peida Liang ; Tian Hu ; Jiayu Lu ; Xiangjun Wang ; Huaxin Zhou ; Wenjing Ta ; Yuejin Wang ; Shemin Lu ; Langchong He	Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus.
000C92 (2020)	Kuma Diriba ; Ephrem Awulachew ; Eyob Getu	The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis.
000D08 (2020)	Vishvanath Tiwari	De novo design, retrosynthetic analysis and combinatorial synthesis of a hybrid antiviral (VTAR-01) to inhibit the interaction of SARS-CoV2 spike glycoprotein with human angiotensin-converting enzyme 2.
000D10 (2020)	Mario B. García-Saavedra ; Renzo R. Rosales-Gutiérrez ; Esmeralda Valverde ; Maryuri Chumbes-Aguirre ; Ricardo Alvarado ; Robert Polo ; Rubén Aza Ero ; Carlos Chávez	[Cardiovascular implications of SARS-CoV-2 infection: A literature review].

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i -k "Angiotensin-Converting Enzyme 2" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i  \
                -Sk "Angiotensin-Converting Enzyme 2" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Angiotensin-Converting Enzyme 2
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021